What is Highgrade Labs?
Highgrade Labs operates as an ISO-accredited, multi-state testing facility providing critical analytical services for the cannabis and CBD sectors. Since its inception in 2019, the company has established a robust market presence across New Jersey, Maryland, and Oklahoma. By leveraging state-of-the-art technology, Highgrade Labs delivers precise assessments, including mycotoxin testing and residual solvent analysis. The firm distinguishes itself through a dual focus on technical accuracy and client education, effectively acting as a compliance partner for businesses navigating the rapidly shifting legal landscape of the cannabis market.
How much funding has Highgrade Labs raised?
Highgrade Labs has raised a total of $3.8M across 1 funding round:
Unspecified
$3.8M
Unspecified (2020): $3.8M, investors not publicly disclosed
Key Investors in Highgrade Labs
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Highgrade Labs?
With this major strategic investment, Highgrade Labs is poised to accelerate its operational footprint and enhance its technological capabilities. The capital will likely be deployed to expand laboratory capacity in existing states and potentially enter new jurisdictions as regulatory frameworks evolve. By prioritizing compliance and scientific rigor, the company is strategically positioned to capture a larger share of the testing market, providing the necessary infrastructure for cannabis producers to meet stringent safety standards. Future growth will likely center on scaling its analytical throughput while maintaining the high-quality standards required for ISO accreditation in a high-stakes industry.
See full Highgrade Labs company page
